ProtAffin in the clinic with modified IL-8 for COPD/CF
This article was originally published in Scrip
Executive Summary
ProtAffin has begun clinical testing of its lead product candidate, the anti-inflammatory PA401AG, a modified form of the human chemokine IL-8.